Literature DB >> 1909456

Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice.

T A Kion1, G W Hoffmann.   

Abstract

Alloimmune mice (mice that have been exposed to cells from another murine strain) were shown to make antibodies against gp120 and p24 of human immunodeficiency virus (HIV), and mice of the autoimmune strains MRL-lpr/lpr and MRL-(+)/+ made antibodies against gp120. This is surprising because the mice were not exposed to HIV. Furthermore, anti-anti-MHC antibodies (molecules that have shapes similar to those of major histocompatibility complex molecules) were detected in both alloimmune sera and MRL mice. These results are discussed in the context of a possible role for allogeneic stimuli in the pathogenesis of acquired immunodeficiency syndrome, as suggested by an idiotypic network model.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909456     DOI: 10.1126/science.1909456

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  23 in total

1.  A gp120 HIV peptide with high similarity to HLA class II beta chains enhances PPD-specific and autoreactive T cell activation.

Authors:  O Pugliese; M Viora; B Camponeschi; P Cordiali Fei; F Caprilli; A Chersi; M Evangelista; A M Di Massimo; V Colizzi
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

2.  Looking beyond the numbers.

Authors:  S Wolf
Journal:  Integr Physiol Behav Sci       Date:  1992 Apr-Jun

3.  Monkey business over AIDS vaccine.

Authors:  R Weiss
Journal:  BMJ       Date:  1991-10-12

4.  Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA.

Authors:  P V Baskar; G D Collins; B A Dorsey-Cooper; R S Pyle; J E Nagel; D Dwyer; G Dunston; C E Johnson; N Kendig; E Israel; D R Nalin; W H Adler
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

Review 5.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

6.  The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection.

Authors:  H J Ditzel; S M Barbas; C F Barbas; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1.

Authors:  T Muster; F Steindl; M Purtscher; A Trkola; A Klima; G Himmler; F Rüker; H Katinger
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  Molecular mimicry between the human immunodeficiency virus type 1 gp120 V3 loop and human brain proteins.

Authors:  J R Trujillo; M F McLane; T H Lee; M Essex
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Rates of amino acid change in the envelope protein correlate with pathogenicity of primate lentiviruses.

Authors:  E G Shpaer; J I Mullins
Journal:  J Mol Evol       Date:  1993-07       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.